News Posts List
Scientists unlock hidden potential of cutting-edge cancer drugs
09/17/2014
A class of cutting-edge cancer drugs could keep patients alive for much longer than they do now following a major new discovery about exactly how they attack tumours.
Predictor of kidney cancer death
09/17/2014
The neutrophil-lymphocyte ratio (NLR) is an indicator of the systemic inflammatory response.
Danish kidney cancer patients dying at an alarming rate
09/12/2014
Survival rates much better in neighbouring countries than at home
Video: Investigators in kidney cancer
09/11/2014
...watch a video about our peer review process & apply for a YIA.
Correlation of radiographic renal cell carcinoma tumor volume utilizing computed tomography
09/11/2014
New evidence suggests that three-dimensional pathological tumor volume (TV) provides additional prognostic information in renal cell carcinoma (RCC) to that provided by tumor size alone.
Treatment of kidney cancer with a novel nanoparticle
09/09/2014
Certain nanoparticles (NP) emit heat energy when excited by near-infrared (NIR) laser energy. We determined efficacy of a novel nanoparticle to induce hyperthermic cellular death of renal cell carcinoma in vitro.
Adjuvant Therapy for RCC
09/05/2014
At the present time, the standard of care for patients who have received nephrectomy for localized renal cell carcinoma (RCC) is radiographic surveillance.
Aggressive bone cancers build more blood vessels
09/04/2014
Osteosarcoma cells expressing high levels of VEGFR1...
Phase I Study of Sunitinib in Combination With Gemcitabine and Capecitabine for First-Line RCC Treatment
09/04/2014
The combination of gemcitabine plus capecitabine and sunitinib (GCS) shows activity in metastatic renal cell carcinoma (mRCC).
mTOR Inhibition Induces Compensatory, Therapeutically Targetable MEK Activation in Renal Cell Carcinoma
09/03/2014
Rapamycin derivatives allosterically targeting mTOR are currently FDA approved to treat advanced renal cell carcinoma (RCC), and catalytic inhibitors of mTOR/PI3K are now in clinical trials for treating various solid tumors.